Allied Digestive Health

Home   >   Our Providers   >  Andrew M. Goldenberg, MD, FACP

Andrew M. Goldenberg, MD, FACP

845-354-3700

Digestive Disease Associates of Rockland

Visit Digestive Disease Associates of Rockland
974 Route 45
Suite 200
Pomona, NY 10970

Education

Bachelor’s Degree – Vanderbilt University

Medical Degree – Boston University

Internship – Boston City Hospital

Residency – Boston City Hospital

Fellowship – Mount Sinai Hospital

Board Certifications – Gastroenterology, Internal Medicine

Honors & Awards

  • Castle Connolly Top Doctors, 2018-present
  • AOA honors in medical school at Boston city Hospital
  • Graduated magma cum Laude from Vanderbilt

Specialties & Main Areas of Interest

  • All GI disorders

Hospital Affiliations

  • Good Samaritan
  • Montefiore Nyack Hospital

Other Appointments

  • Clinical Instructor, Mount Sinai Medical Center

Research

  • Goldenberg, A.M, Present, D.H., Bauer, J., Gordon, R. Islet Cell Tumor Presenting as Massive Upper Gastrointestinal Bleeding in Pregnancy. American Journal of Gastroenterology: 1988;83: 873-75
  • Goldenberg, A.M, Wexler, L.F. Quinine Overdose: Review of Toxicity and Treatment Clinical Cardiology 1988; II :716-18
  • Itzkowitz, S.H., Lee H, Hanauer S, Goldenberg, A.M, Kim, Y.S. New Biochemical Markers Associates with Dysplasia in Ulcerative Colitis Gastroenterology 1987;92 (5): 1449
  • Itzkowitz, S.H, Lee H, Hanauer, S, Goldenberg, A.M, Kim, Y.S. Cancer-Associated Alterations in Blood Group Antigen Expression Occurring in Ulcerative Colitis.
  • 2000 – Rabeprazole FAST trial (Janssen)
  • 2000 – A Twelve Week Randomized Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Alosetron Hydrochloride 1 mg. Twice daily for the control of bowel urgency in females with non-constipated JBS in an Independent Practitioner Association Model. Protocol #S3B40051
  • 2000 – START: Standard Therapeutic Assessment of Rebetron Trial. Indiana University, Indiana Gastroenterology 1988;94 (5); 1449
  • 2000 – A Comparative Efficacy Study of Esomeprazole Magnesium (40 mg qd) and Lansoprazole (30mgs qd) in Patients with Erosive Esophagitis. Protocol #267
  • May 2001 – Completed: Roche Laboratories, Inc. A Prospective Randomized Multicenter, Open Label, Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin in Treatment of Patients with Hep C “Wings Trial”.
  • March 2001 – Completed: Proctor & Gamble. Asacol 4.8gm/day vs 2.4 gm/day in mild to moderate ulcerative colitis patients experiencing an active flare.
  • April 2003 – Abbott Laboratories: A Multi-Center, Randomized, Double-Blind, Placebo­Controlled Study of Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease.
  • September 2003 – GlaxoSmithK.line-A 12-week, Randomized, Double-Blind, Placebo­ Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects with Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy.

Fun Facts

  • Dr. Goldenberg enjoys playing golf, fishing, exercising, and traveling. He also
    was a jazz lead trumpet player and has recorded three albums.

Conditions Treated

Procedures Performed

© Allied Digestive Health. All Rights Reserved.

Are you finding it challenging to lose weight despite your efforts with diet and exercise?

We understand the complexities of weight loss. That’s why we’re excited to announce our new partnership with KORB Health to offer a medical weight loss program that includes the medication Semaglutide (same active ingredient as Ozempic).
CLICK HERE TO LEARN MORE

Appointment Locations